Pharmaceuticals
51 recent notes from companies in this sector. 20 companies tracked.
Anchor companies · by market cap
SUNPHARMA ₹4.43 lakh cr TORNTPHARM ₹1.52 lakh cr CIPLA ₹1.13 lakh cr DRREDDY ₹1.09 lakh cr ZYDUSLIFE ₹1.05 lakh cr LUPIN ₹1.04 lakh cr MANKIND ₹1.02 lakh cr AUROPHARMA ₹84,206 cr BIOCON ₹69,739 cr ALKEM ₹64,618 cr GLENMARK ₹63,751 cr ABBOTINDIA ₹59,136 cr IPCALAB ₹40,543 cr GLAXO ₹39,080 cr AJANTPHARM ₹38,823 cr JBCHEPHARM ₹35,204 cr
Recent activity
22 May · 20:46 IST 6 INFLUX 22 May · 20:39 IST 9 GUJTHEM 22 May · 19:47 IST 6 SUNPHARMA 22 May · 18:40 IST 6 TORNTPHARM 22 May · 18:35 IST 6 SYNCOMF 22 May · 17:02 IST 5 TORNTPHARM 22 May · 16:57 IST 6 TORNTPHARM 22 May · 16:43 IST 5 UNICHEMLAB 22 May · 15:54 IST 6 LUPIN 22 May · 15:20 IST 5 SMSPHARMA 22 May · 15:16 IST 5 SMSPHARMA 22 May · 15:04 IST 6 SUNPHARMA 22 May · 14:58 IST 6 SHILPAMED 22 May · 14:58 IST 6 SHILPAMED 22 May · 14:56 IST 5 SUNPHARMA 22 May · 13:57 IST 5 SMSPHARMA 22 May · 13:54 IST 6 WINDLAS 22 May · 12:08 IST 6 SUDEEPPHRM 22 May · 11:56 IST 8 VENUSREM 21 May · 17:50 IST 6 AMANTA 21 May · 17:46 IST 5 MEDICO 21 May · 17:39 IST 6 WINDLAS 21 May · 17:12 IST 6 MEDPLUS 21 May · 16:54 IST 5 WINDLAS 21 May · 16:36 IST 5 GANGAPHARM 21 May · 16:34 IST 5 WINDLAS 21 May · 16:27 IST 5 GANGAPHARM 21 May · 16:21 IST 5 SUDEEPPHRM 21 May · 16:07 IST 5 SUDEEPPHRM 21 May · 15:31 IST 6 APLLTD 21 May · 14:50 IST 6 AAYUSH 21 May · 14:42 IST 5 WOCKPHARMA 21 May · 13:55 IST 5 STAR 21 May · 13:31 IST 7 ADESHWAR 21 May · 13:27 IST 8 ASTRAZEN 21 May · 13:24 IST 5 KREBSBIO 21 May · 12:53 IST 5 IOLCP 21 May · 12:53 IST 5 ANUHPHR 21 May · 12:41 IST 5 AKUMS 21 May · 08:15 IST 6 VIYASH 20 May · 23:56 IST 5 ANUHPHR 20 May · 22:52 IST 5 ANUHPHR 20 May · 22:03 IST 6 STAR 20 May · 21:58 IST 5 ANUHPHR 20 May · 21:07 IST 6 MEDPLUS 20 May · 20:21 IST 5 SGRL 20 May · 19:11 IST 5 MOREPENLAB 20 May · 19:09 IST 5 AKUMS 20 May · 19:06 IST 6 GUJINJEC 20 May · 19:01 IST 6 GUJINJEC 20 May · 18:39 IST 6 IOLCP
Brief · Concalls
Influx Healthtech walks back FY27 revenue doubling goal
Alert · M&A
Gujarat Themis Biosyn bets ₹1,300 cr to buy Japan's MicroBiopharm
Brief · Other
Sun Pharma's US innovation revenue overtakes its generics business
Brief · Concalls
Torrent Pharma walks back US growth targets to single digits
Brief · Earnings
Syncom Formulations profit jumps 55% as revenue gains slow
Brief · Earnings
Torrent Pharmaceuticals FY26 results confirm revenue growth of 21%
Brief · Earnings
Torrent Pharmaceuticals eyes ₹5,000 cr QIP following JB Pharma buy
Brief · Earnings
Unichem Laboratories annual profit fell on labour code charges
Brief · Other
Lupin wins its first drug approval in China
Brief · Earnings
SMS Pharmaceuticals books ₹87.61 cr annual profit
Brief · Earnings
SMS Pharmaceuticals hits ₹87.61 cr profit as FY26 growth hits target
Brief · Earnings
Sun Pharma posts 26% Q4 profit growth and readies tax shift
Brief · Earnings
Shilpa Medicare profit hits ₹108 cr as pharma operations turn around
Brief · Earnings
Shilpa Medicare profit triples to ₹243 cr
Brief · Earnings
Sun Pharmaceutical FY26 growth hits 11.9% as dividends hold steady
Brief · Earnings
SMS Pharmaceuticals grows FY26 revenue to ₹886.87 cr
Brief · Concalls
Windlas Biotech misses Plant 6 timeline as regulatory hit cuts revenue
Brief · Concalls
Sudeep Pharma revenue climbs 28%, but project delays and working capital bite
Lead · Regulatory
Venus Remedies enters Saudi market with Plerixafor approval
Brief · Earnings
Amanta Healthcare eyes 24-25% EBITDA margin as new lines come online
Brief · Earnings
Medico Remedies closes FY26 with 37% revenue growth, no surprises
Brief · Earnings
Windlas Biotech’s ₹904 Cr revenue: record, but already priced in.
Brief · Earnings
MedPlus targets 800 new stores in FY27, private label margins recover
Brief · Earnings
Windlas lifts dividend to ₹6.30 as profit rises 9% in FY26
Brief · Earnings
Ganga Pharma's FY26 results show modest uptick, no surprises
Brief · Earnings
Windlas Biotech meets FY26 estimates; dividend raised to ₹6.30
Brief · Earnings
Ganga Pharma FY26 revenue inches up 7% to ₹282.79 lakhs
Brief · Earnings
Sudeep Pharma FY26: Revenue up 28%, PAT at ₹174 cr
Brief · Earnings
Sudeep Pharma wraps FY26 with 28% revenue growth, 26% PAT jump
Brief · Earnings
Alembic sets FY27 revenue growth target at low double digits
Brief · Regulatory
Aayush Wellness appoints auditor after mid-tenure exit
Brief · Credit
Wockhardt's credit quality just improved — but the market already knew
Brief · Earnings
Strides Pharma Q4 transcript: nothing new from May 18 call
Lead · Credit
Adeshwar Meditex eyes ₹40 cr equity raise – nearly double its market cap
Lead · Other
AstraZeneca India wins CDSCO nod for Calquence in MCL
Brief · Earnings
Krebs Biochemicals revenue halved as Vizag plant stays shut
Brief · Earnings
IOL Chem's Q4 & FY26 results: Old news, no surprises
Brief · Earnings
Anuh Pharma's FY26 revenue rose 16.6% but profit fell 13.3%
Brief · Earnings
Akums FY26 call transcript adds nothing new after earlier disclosure
Brief · Concalls
Viyash Scientific targets ₹1,000 cr EBITDA in 2-3 years, pivots to companion animals
Brief · Earnings
Anuh Pharma revenue up 16%, but profit slips 13% in FY26
Brief · Earnings
Anuh Pharma's profit slipped 13% even as revenue rose 17% in FY26
Brief · Other
Strides Pharma's flagship plant draws 5 FDA observations
Brief · Earnings
Anuh Pharma's profit slipped 13% despite 16.6% revenue growth
Brief · Earnings
MedPlus profit jumps 46% to ₹2,196.1 mn, revenue up 12% to ₹68,924.6 mn
Brief · Earnings
Shree Ganesh Remedies' Q4 call transcript: already old news
Brief · Other
Morepen locks in medical devices chief with subsidiary shares
Brief · Order Wins
Akums gets ₹133.75 cr tax notice, says it will appeal
Brief · Earnings
Gujarat Inject (Kerala) posts 7x revenue jump in Q4, flips to profit
Brief · Earnings
Gujarat Inject (Kerala) Q4 revenue zooms 19x to ₹30.7 cr
Brief · Earnings